Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis.
about
Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung InfectionsExperimental evolution in biofilm populations.The Unspecific Side of Acquired Immunity Against Infectious Disease: Causes and ConsequencesUltrafast evolution and loss of CRISPRs following a host shift in a novel wildlife pathogen, Mycoplasma gallisepticum(1)H-NMR-Based Endometabolome Profiles of Burkholderia cenocepacia Clonal Variants Retrieved from a Cystic Fibrosis Patient during Chronic InfectionNon-traditional antibacterial screening approaches for the identification of novel inhibitors of the glyoxylate shunt in gram-negative pathogensPseudomonas aeruginosa PA1006, which plays a role in molybdenum homeostasis, is required for nitrate utilization, biofilm formation, and virulenceEvolution of Genome Size in Asexual Digital OrganismsGenotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strains.Archetypal analysis of diverse Pseudomonas aeruginosa transcriptomes reveals adaptation in cystic fibrosis airwaysMetabolic network analysis of Pseudomonas aeruginosa during chronic cystic fibrosis lung infectionPhysiological levels of nitrate support anoxic growth by denitrification of Pseudomonas aeruginosa at growth rates reported in cystic fibrosis lungs and sputum.Robustness and plasticity of metabolic pathway flux among uropathogenic isolates of Pseudomonas aeruginosa.Tangled bank of experimentally evolved Burkholderia biofilms reflects selection during chronic infectionsRegA Plays a Key Role in Oxygen-Dependent Establishment of Persistence and in Isocitrate Lyase Activity, a Critical Determinant of In vivo Brucella suis Pathogenicity.The multiple roles of hypothetical gene BPSS1356 in Burkholderia pseudomallei.Achromobacter xylosoxidans genomic characterization and correlation of randomly amplified polymorphic DNA profiles with relevant clinical features [corrected] of cystic fibrosis patients.The Pseudomonas aeruginosa AlgZR two-component system coordinates multiple phenotypes.Pseudomonas aeruginosa AES-1 exhibits increased virulence gene expression during chronic infection of cystic fibrosis lung.Development of an ex vivo porcine lung model for studying growth, virulence, and signaling of Pseudomonas aeruginosa.Evolution and adaptation in Pseudomonas aeruginosa biofilms driven by mismatch repair system-deficient mutators.Genomic expression analysis reveals strategies of Burkholderia cenocepacia to adapt to cystic fibrosis patients' airways and antimicrobial therapy.The Pseudomonas aeruginosa reference strain PA14 displays increased virulence due to a mutation in ladS.Parallel evolution in Pseudomonas aeruginosa over 39,000 generations in vivo.Small regulatory RNAs in Pseudomonas aeruginosa.Clinical significance of microbial infection and adaptation in cystic fibrosis.Molecular epidemiology of chronic Pseudomonas aeruginosa airway infections in cystic fibrosis.Fast and effective photodynamic inactivation of multiresistant bacteria by cationic riboflavin derivativesClonal dissemination, emergence of mutator lineages and antibiotic resistance evolution in Pseudomonas aeruginosa cystic fibrosis chronic lung infection.Proposal of a quantitative PCR-based protocol for an optimal Pseudomonas aeruginosa detection in patients with cystic fibrosis.Proteomic profiling of Burkholderia cenocepacia clonal isolates with different virulence potential retrieved from a cystic fibrosis patient during chronic lung infection.The evolving dynamics of the microbial community in the cystic fibrosis lung.Complete Genome Sequence of Pseudomonas aeruginosa Mucoid Strain FRD1, Isolated from a Cystic Fibrosis Patient.Proteomic analysis of colony morphology variants of Burkholderia pseudomallei defines a role for the arginine deiminase system in bacterial survivalHomogentisate 1-2-Dioxygenase Downregulation in the Chronic Persistence of Pseudomonas aeruginosa Australian Epidemic Strain-1 in the CF LungSelective Sweeps and Parallel Pathoadaptation Drive Pseudomonas aeruginosa Evolution in the Cystic Fibrosis Lung.Functional characterization of the Mycobacterium abscessus genome coupled with condition specific transcriptomics reveals conserved molecular strategies for host adaptation and persistenceLong-term colonization of the cystic fibrosis lung by Burkholderia cepacia complex bacteria: epidemiology, clonal variation, and genome-wide expression alterations.Identification of essential genes of Pseudomonas aeruginosa for its growth in airway mucus.Microenvironmental characteristics and physiology of biofilms in chronic infections of CF patients are strongly affected by the host immune response.
P2860
Q26768034-7A0BF313-C0E0-458B-97A9-30BFDE43BD05Q26768691-62913008-6DC7-4BFE-96F3-813E78710BB6Q26770395-59644B8B-2424-413E-88B2-78C86AB5EC99Q27334811-FCAB82FF-3552-4E28-9D7D-2A36EF3081F0Q28354078-85E7902C-63C7-4EAA-B849-261A66C26DD9Q28484292-ED623ADD-7FC9-43CB-87F7-5CAAE7BC00AFQ28492614-1EC35CD8-C1BF-477B-B231-DC4E98467B32Q28602743-423DE444-20DF-46E2-9DB4-587F094358B0Q30278439-B439FBAD-2D31-475B-A10A-751D456E6923Q30336845-DC2F8751-2AB0-4F55-9B8C-780720F28047Q30432839-9937B02C-0A54-4C98-9FE8-65A605FAEE12Q30868724-0BBF4C63-43F6-4A5A-8975-FFE27B6FFC1DQ31157916-8AA90418-1243-4BFF-856E-C659B0526ACFQ33455287-871998C7-42B1-46BB-A157-C4E1532D7510Q33700813-F21FC9EE-4D7D-492C-BF17-726DC6A649BAQ33753510-93786D06-0B19-4714-908E-5AE22715148DQ33769610-F1DF2700-FB21-4D57-B058-8E20BF68CB61Q33780971-962DEB2E-06CF-44A8-914C-C44E31D23A6AQ34026130-FB04F202-38E1-48EB-93A6-D4179C1EBCE0Q34059034-BF290B88-4CED-4ACD-A64E-A45EF436433EQ34082906-A05E7ED5-3585-4331-9303-96BB2F147A8BQ34117003-DB300DA9-7F21-4FD1-B6A5-186E756B4ECBQ34117212-9B6B980B-7B63-4FB5-AA95-DEED3B447A6FQ34128914-AA972CF8-81BE-4B3A-9400-2E6195DF3563Q34254544-7CEC62DB-70D7-4107-B145-552E0852A5A6Q34491552-4B1BA12D-7C85-48B2-AF62-38CDD1FF7467Q34500683-95F4BC3F-3ED6-44F8-907B-0F61523C2B15Q34623924-9FB689B2-2C1F-4B7E-AD3E-33F0241E83A6Q34948367-9EA86A9B-F531-4730-BC6A-2A2D79AF3D0FQ35006748-B420B7B0-EE88-46B0-B184-6609A4CD6685Q35070750-901145D8-A825-4F1B-9055-D562AAFECE8CQ35163645-85CDB37E-FFFC-4C1E-861A-BEFFD4CF25A7Q35389378-1269302B-6C34-4D95-A345-F9E699ED7D92Q35715035-83305E17-02B4-4382-966E-C1F03F38F0ECQ35739755-B706A969-13A3-42BF-B3C6-E317B69C20C4Q35761876-B2FA768B-2AFE-4917-8DE2-955ECCE15F74Q36096266-951F7A9F-BFDA-4413-9A9E-3C8CE82651E1Q36158775-678DFD7F-6C0D-40CD-92B6-EE2781291593Q36236143-733C0B9F-2A9E-4929-9172-272C66DEFF7AQ36346231-41C300A3-223F-4069-AE1E-AE4A81A3D6DE
P2860
Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Dynamics of adaptive microevol ...... patients with cystic fibrosis.
@en
Dynamics of adaptive microevol ...... patients with cystic fibrosis.
@nl
type
label
Dynamics of adaptive microevol ...... patients with cystic fibrosis.
@en
Dynamics of adaptive microevol ...... patients with cystic fibrosis.
@nl
prefLabel
Dynamics of adaptive microevol ...... patients with cystic fibrosis.
@en
Dynamics of adaptive microevol ...... patients with cystic fibrosis.
@nl
P2093
P921
P356
P1476
Dynamics of adaptive microevol ...... patients with cystic fibrosis.
@en
P2093
Anja Eichner
Christina Hoboth
Christine Henke
Jürgen Heesemann
Michael Hogardt
Sabine Schmoldt
P304
P356
10.1086/599360
P407
P577
2009-07-01T00:00:00Z